scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007691-200106000-00017 |
P698 | PubMed publication ID | 11360039 |
P2093 | author name string | K Bodin | |
L Bertilsson | |||
S Morita | |||
C Ursing | |||
G Tybring | |||
S Härtter | |||
P4510 | describes a project that uses | liquid chromatography–mass spectrometry | Q873864 |
P433 | issue | 3 | |
P921 | main subject | melatonin | Q180912 |
P304 | page(s) | 282-286 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Therapeutic Drug Monitoring | Q15724567 |
P1476 | title | Determination of exogenous melatonin and its 6-hydroxy metabolite in human plasma by liquid chromatography-mass spectrometry | |
P478 | volume | 23 |
Q36790186 | Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase |
Q77361626 | Bibliography. Current literature in mass spectrometry |
Q51197352 | Determination of melatonin in saliva using automated solid-phase extraction, high-performance liquid chromatography and fluorescence detection. |
Q34788841 | Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis |
Q44530679 | Quantification of melatonin in human saliva by liquid chromatography-tandem mass spectrometry using stable isotope dilution |
Q42223344 | Sulfation of 6-hydroxymelatonin, N-acetylserotonin and 4-hydroxyramelteon by the human cytosolic sulfotransferases (SULTs). |